Disease-specific Research Programs

Disease-specific programs comprise a significant proportion of the research conducted at the Human Microbiology Institute. The founders of the HMI have made amazing studies in advancing our understating of the mechanisms by which the microbiota influences human diseases, including several diseases that were previously not considered to be infectious.

Our latest discoveries provide us with the ability to rethink how we treat and prevent neurodegenerative and autoimmune diseases and to bring their therapy to a new level of efficacy

We have discovered principally new mechanisms of microbiota-host interactions, which provide a basis for the next-generation of microbiota research aimed at understanding how diseases, including age-related and neurodegenerative diseases, are developed and established, and at successfully identifying new ways of preventing and managing these disorders.